U.S., Canada, begin trauma experiments

May 27, 2007

The U.S. government is undertaking a set of controversial studies that allows some medical experiments without getting patients' permission.

The $50 million project aims to improve treatment after car accidents, shootings, heart attack and other emergencies, the Washington Post reported Sunday. The five-year project will involve more than 20,000 patients at 11 sites in the United States and Canada.

The experiments aim to find better ways to resuscitate people whose hearts suddenly stop, to stabilize patients in shock and to limit damage from head injuries, the Post reported.

The patients often are unconscious at a time when every minute counts, so it can be impossible to get consent from them or their families, said organizers of the studies. The project is supported by many trauma experts and some bioethicists, while the harshest critics say the experiments violate fundamental ethical principles.

The U.S. National Institutes of Health authorized the study for medical centers doing research in Seattle, Portland, San Diego, Dallas, Birmingham, Pittsburgh, Milwaukee, Toronto and Ottawa, and in Iowa and British Columbia.

Copyright 2007 by United Press International

Explore further: FDA OKs Cubist antibiotic for serious infections

add to favorites email to friend print save as pdf

Related Stories

New technology reduces size of spinal stimulator implants

Nov 20, 2014

Spinal cord stimulator implants could use less power and be made much smaller as work from Taiwan and Israel eliminates off-chip high-voltage devices from the implant's pulse generator. This will reduce implant-related ...

Simulation predicts epidermal responses to compounds

Nov 18, 2014

Skin is the body's largest organ. It is a protective barrier, keeping microbes out and moisture in. It also regulates temperature, enables sensation, and makes vitamin D. But researchers don't fully understand ...

Recommended for you

FDA OKs Cubist antibiotic for serious infections

Dec 20, 2014

The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May.

Xtoro approved for swimmer's ear

Dec 18, 2014

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

Drug interaction identified for ondansetron, tramadol

Dec 18, 2014

(HealthDay)—In the early postoperative period, ondansetron is associated with increased requirements for tramadol consumption, according to a review and meta-analysis published online Dec. 10 in Anaesthesia.

New system targets germs in donated blood plasma

Dec 17, 2014

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.